Erika Hammarlund

3.6k total citations · 1 hit paper
24 papers, 2.0k citations indexed

About

Erika Hammarlund is a scholar working on Virology, Immunology and Infectious Diseases. According to data from OpenAlex, Erika Hammarlund has authored 24 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Virology, 11 papers in Immunology and 8 papers in Infectious Diseases. Recurrent topics in Erika Hammarlund's work include Poxvirus research and outbreaks (13 papers), Immunotherapy and Immune Responses (7 papers) and Bacillus and Francisella bacterial research (6 papers). Erika Hammarlund is often cited by papers focused on Poxvirus research and outbreaks (13 papers), Immunotherapy and Immune Responses (7 papers) and Bacillus and Francisella bacterial research (6 papers). Erika Hammarlund collaborates with scholars based in United States, Netherlands and India. Erika Hammarlund's co-authors include Mark K. Slifka, Matthew W. Lewis, Jon M. Hanifin, Scott G. Hansen, Lisa Strelow, Jay A. Nelson, Gerard P. Sexton, Ian J. Amanna, Hans-Peter Raué and Klaus Früh and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Nature Communications.

In The Last Decade

Erika Hammarlund

22 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Duration of antiviral immunity after smallpox vaccination

2003 691 citations Erika Hammarlund, Matthew W. Lewis et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Erika Hammarlund United States	16	944	877	755	738	369	24	2.0k
Godwin Nchinda United States	18	1.1k 1.2×	707 0.8×	496 0.7×	892 1.2×	247 0.7×	34	2.1k
Ludwig Deml Germany	23	765 0.8×	488 0.6×	431 0.6×	523 0.7×	268 0.7×	53	1.5k
Melissa Kane United States	13	678 0.7×	530 0.6×	311 0.4×	493 0.7×	506 1.4×	22	1.5k
Ismar R. Haga United Kingdom	16	915 1.0×	484 0.6×	637 0.8×	358 0.5×	234 0.6×	19	1.5k
Linda S. Klavinskis United Kingdom	27	1.5k 1.6×	627 0.7×	580 0.8×	499 0.7×	500 1.4×	56	2.4k
Mark L. Bagarazzi United States	20	1.3k 1.4×	621 0.7×	585 0.8×	687 0.9×	428 1.2×	38	2.0k
Kesen Dang United States	22	1.6k 1.7×	647 0.7×	570 0.8×	807 1.1×	535 1.4×	27	2.4k
James T. Fuller United States	17	893 0.9×	472 0.5×	487 0.6×	457 0.6×	446 1.2×	26	1.5k
Markus Moll Sweden	26	1.2k 1.3×	404 0.5×	776 1.0×	202 0.3×	357 1.0×	36	1.9k
Timothy Fouts United States	27	1.0k 1.1×	1.3k 1.5×	383 0.5×	530 0.7×	690 1.9×	53	2.1k

Countries citing papers authored by Erika Hammarlund

Since Specialization

Citations

This map shows the geographic impact of Erika Hammarlund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erika Hammarlund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erika Hammarlund more than expected).

Fields of papers citing papers by Erika Hammarlund

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erika Hammarlund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erika Hammarlund. The network helps show where Erika Hammarlund may publish in the future.

Co-authorship network of co-authors of Erika Hammarlund

This figure shows the co-authorship network connecting the top 25 collaborators of Erika Hammarlund. A scholar is included among the top collaborators of Erika Hammarlund based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erika Hammarlund. Erika Hammarlund is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Amanna, Ian J., Archana Thomas, Flora Engelmann, et al.. (2024). Development of a hydrogen peroxide-inactivated vaccine that protects against viscerotropic yellow fever in a non-human primate model. Cell Reports Medicine. 5(7). 101655–101655. 5 indexed citations

Hammarlund, Erika, Archana Thomas, Ian J. Amanna, et al.. (2017). Plasma cell survival in the absence of B cell memory. Nature Communications. 8(1). 1781–1781. 139 indexed citations

Hammarlund, Erika, Archana Thomas, Ian J. Amanna, et al.. (2016). Durability of Vaccine-Induced Immunity Against Tetanus and Diphtheria Toxins: A Cross-sectional Analysis. Clinical Infectious Diseases. 62(9). 1111–1118. 73 indexed citations

Raué, Hans-Peter, Archana Thomas, Erika Hammarlund, et al.. (2016). Pre-clinical development of a hydrogen peroxide-inactivated West Nile virus vaccine. Vaccine. 35(2). 283–292. 18 indexed citations

Alzhanova, Dina, Erika Hammarlund, Jason S. Reed, et al.. (2014). T Cell Inactivation by Poxviral B22 Family Proteins Increases Viral Virulence. PLoS Pathogens. 10(5). e1004123–e1004123. 42 indexed citations

Engelmann, Flora, Laurence Josset, Thomas Girke, et al.. (2014). Pathophysiologic and Transcriptomic Analyses of Viscerotropic Yellow Fever in a Rhesus Macaque Model. PLoS neglected tropical diseases. 8(11). e3295–e3295. 50 indexed citations

Slifka, Mark K., Donald Y.M. Leung, Erika Hammarlund, et al.. (2013). Transcutaneous yellow fever vaccination of subjects with or without atopic dermatitis. Journal of Allergy and Clinical Immunology. 133(2). 439–447. 17 indexed citations

Hammarlund, Erika, et al.. (2012). Regulation of innate CD8 ⁺ T-cell activation mediated by cytokines. Proceedings of the National Academy of Sciences. 109(25). 9971–9976. 175 indexed citations

Hammarlund, Erika, et al.. (2012). Optimization of Peptide-Based ELISA for Serological Diagnostics: A Retrospective Study of Human Monkeypox Infection. Vector-Borne and Zoonotic Diseases. 12(5). 400–409. 64 indexed citations

10.

Hammarlund, Erika, Ian J. Amanna, Alex Barron, et al.. (2012). A Flow Cytometry-Based Assay for Quantifying Non-Plaque Forming Strains of Yellow Fever Virus. PLoS ONE. 7(9). e41707–e41707. 10 indexed citations

11.

Hammarlund, Erika, Matthew W. Lewis, Jon M. Hanifin, et al.. (2010). Antiviral Immunity following Smallpox Virus Infection: a Case-Control Study. Journal of Virology. 84(24). 12754–12760. 46 indexed citations

12.

Hirao, Lauren A., Ruxandra Draghia‐Akli, Maria Yang, et al.. (2010). Multivalent Smallpox DNA Vaccine Delivered by Intradermal Electroporation Drives Protective Immunity in Nonhuman Primates Against Lethal Monkeypox Challenge. The Journal of Infectious Diseases. 203(1). 95–102. 85 indexed citations

13.

Alzhanova, Dina, Erika Hammarlund, Isabel Scholz, et al.. (2009). Cowpox Virus Inhibits the Transporter Associated with Antigen Processing to Evade T Cell Recognition. Cell Host & Microbe. 6(5). 433–445. 63 indexed citations

14.

Hammarlund, Erika, et al.. (2008). Monkeypox virus evades antiviral CD4 ⁺ and CD8 ⁺ T cell responses by suppressing cognate T cell activation. Proceedings of the National Academy of Sciences. 105(38). 14567–14572. 121 indexed citations

15.

Dasgupta, Anindya, Erika Hammarlund, Mark K. Slifka, & Klaus Früh. (2007). Cowpox Virus Evades CTL Recognition and Inhibits the Intracellular Transport of MHC Class I Molecules. The Journal of Immunology. 178(3). 1654–1661. 52 indexed citations

16.

Simpson, Eric L., et al.. (2007). Cutaneous responses to vaccinia in individuals with previous smallpox vaccination. Journal of the American Academy of Dermatology. 57(3). 442–444. 7 indexed citations

17.

Hammarlund, Erika, Matthew W. Lewis, Jon M. Hanifin, et al.. (2007). Traditional smallpox vaccination with reduced risk of inadvertent contact spread by administration of povidone iodine ointment. Vaccine. 26(3). 430–439. 10 indexed citations

18.

Hammarlund, Erika, Matthew W. Lewis, Ian J. Amanna, et al.. (2005). Multiple diagnostic techniques identify previously vaccinated individuals with protective immunity against monkeypox. Nature Medicine. 11(9). 1005–1011. 224 indexed citations

19.

Brien, James D., et al.. (2004). Activation of Virus-Specific CD8+ T Cells by Lipopolysaccharide-Induced IL-12 and IL-18. The Journal of Immunology. 173(11). 6873–6881. 82 indexed citations

20.

Hammarlund, Erika, Matthew W. Lewis, Scott G. Hansen, et al.. (2003). Duration of antiviral immunity after smallpox vaccination. Nature Medicine. 9(9). 1131–1137. 691 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact